What are the public policy implications of a neurobiological view of addiction?

Addiction

Volumn 107, Issue 7, 2012, Pages 1199-1200

  Gartner, Coral E ^a   Carter, Adrian ^a   Partridge, Brad ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Addiction treatment; Behavioural addictions; Medical model; Neuroscience; Public health policy; Self efficacy; Smoking; Substance use

Indexed keywords

ADDICTION; BRAIN DISEASE; EDITORIAL; HEALTH CARE POLICY; HUMAN; POLICY; PSYCHOLOGICAL ASPECT;

BRAIN DISEASES; HEALTH POLICY; HUMANS; PUBLIC POLICY; SUBSTANCE-RELATED DISORDERS;

EID: 84861933453     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.03812.x     Document Type: Editorial

References (19)

1. Robison A. J., Nestler E. J. Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 2011; 12: 623-37.
2. Kenny P. J. Common cellular and molecular mechanisms in obesity and drug addiction. Nat Rev Neurosci 2011; 12: 638-51.
3. Epstein D. H., Shaham Y. Cheesecake-eating rats and the question of food addiction. Nat Neurosci 2010; 13: 529-31.
4. Holden C. 'Behavioral' addictions: do they exist? Science 2001; 294: 980-2.
5. American Society of Addiction Medicine (ASAM). Public Policy Statement: Definition of Addiction [long version]. Chevy Chase, MD: ASAM; 2011.
6. Dackis C., O'Brien C. Neurobiology of addiction: treatment and public policy ramifications. Nat Neurosci 2005; 8: 1431-6.
7. Kadden R. M., Litt M. D. The role of self-efficacy in the treatment of substance use disorders. Addict Behav 2011; 36: 1120-6.
8. Laviolette S., van der Kooy D. The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat Rev Neurosci 2004; 5: 55-65.
9. Chapman S., MacKenzie R. The global research neglect of unassisted smoking cessation: causes and consequences. PLoS Med 2010; 296: 2480-2.
10. Harackiewicz J. M., Sansone C., Blair L., Lester W., Epstein J. A., Manderlink G. Attributional processes in behavior change and maintenance: smoking cessation and continued abstinence. J Consult Clin Psychol 1987; 55: 372-8.
11. Heyman G. Addiction: A Disorder of Choice. Cambridge, MA: Harvard University Press; 2009.
12. Press N. Social construction and medicalization: behavioural genetics in context. In: Parens E., Chapman A. R., Press N., editors. Wrestling with Behavioral Genetics: Science, Ethics and Public Conversation. Baltimore: Johns Hopkins University Press; 2005, p. 131-49.
13. Hall W., Gartner C. Ethical issues in using drug vaccines to treat and prevent cocaine and nicotine dependence. Curr Opin Psychiatry 2011; 24: 191-6.
14. Carter A., Hall W. D. Proposals to trial deep brain stimulation to treat addiction are premature. Addiction 2011; 106: 235-7.
15. Caron L., Karkazis K., Raffin T. A., Swan G., Koenig B. A. Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking. Nicotine Tob Res 2005; 7: 181-97.
16. Gartner C. E., Barendregt J. J., Hall W. D. Multiple genetic tests for susceptibility to smoking do not outperform simple family history. Addiction 2009; 104: 118-26.
17. Welberg L. Addiction: from mechanisms to treatment. Nat Rev Neurosci 2011; 12: 621.
18. Glynn T., Seffrin J. R., Brawley O. W., Grey N. and Ross H. The globalization of tobacco use: 21 challenges for the 21st century. CA Cancer J Clin 2010; 60: 50-61.
19. Gundle K. R., Dingel M. J., Koenig B. A. 'To prove this is the industry's best hope': big tobacco's support of research on the genetics of nicotine addiction. Addiction 2010; 105: 974-83.